Susquehanna International Group’s Elanco Animal Health Incorporated 5.00% Tangible Equity Units ELAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-11,642
Closed -$243K 14306
2022
Q3
$243K Buy
11,642
+1,742
+18% +$49.8K ﹤0.01% 10346
2022
Q2
$317K Sell
9,900
-16
-0.2% -$603 ﹤0.01% 9428
2022
Q1
$404K Buy
+9,916
New +$415K ﹤0.01% 9526

Other funds holding ELAT

Susquehanna International Group's ELAT Position: Q4 2022 in Review

Susquehanna International Group sold out of Elanco Animal Health Incorporated 5.00% Tangible Equity Units (ELAT) in Q4 2022, closing a stake of 11,642 shares — an estimated $243K sold.

Susquehanna International Group first reported a position in ELAT in Q1 2022 and held it in 3 quarters. The position peaked at $404K in Q1 2022. 27 funds tracked by Wall St. Rank hold ELAT as of Q4 2022.

  • Susquehanna International Group reported no remaining Elanco Animal Health Incorporated 5.00% Tangible Equity Units position as of Q4 2022 after selling out during the quarter.
  • Susquehanna International Group sold 11,642 Elanco Animal Health Incorporated 5.00% Tangible Equity Units shares in Q4 2022, an estimated $243K.
  • Susquehanna International Group first reported a position in Elanco Animal Health Incorporated 5.00% Tangible Equity Units in Q1 2022 and held it in 3 quarters.
  • Susquehanna International Group's Elanco Animal Health Incorporated 5.00% Tangible Equity Units position peaked at $404K in Q1 2022.
  • 27 funds tracked by Wall St. Rank held Elanco Animal Health Incorporated 5.00% Tangible Equity Units as of Q4 2022.

Based on Susquehanna International Group's 13F filing for Q4 2022, filed 14 Feb 2023.